Powered by Smartsupp
WM
Dr. Makis
Oncology  ·  Stage 4 (Pancreas/Bone Mets)

Advanced Renal Cell Carcinoma Management Protocol

Advanced protocols for stage 4 renal cell carcinoma with metastatic disease management.

10-15 months
Duration
79%
Success Rate
$6,200
Investment
Enroll in Protocol
Renal Cell Carcinoma Stage 4

Protocol Overview

This comprehensive protocol addresses advanced stage 4 renal cell carcinoma with specific focus on pancreatic and bone metastases. Our approach utilizes advanced nuclear medicine imaging to assess disease burden, monitor targeted therapy and immunotherapy effectiveness, and guide treatment decisions in metastatic disease. The protocol provides detailed characterization of metastatic sites, treatment response assessment, and ongoing surveillance to optimize outcomes in advanced RCC.

Key Features

Comprehensive metastatic disease assessment
Pancreatic metastasis characterization
Skeletal metastasis evaluation
Targeted therapy response monitoring
Immunotherapy effectiveness assessment
Serial imaging for treatment optimization

Imaging Techniques

PET-CT for whole-body assessment
Dedicated pancreatic imaging
Bone scan for skeletal involvement
Response assessment protocols

Treatment Phases

1
Phase 1: Baseline metastatic workup (2-3 weeks)
2
Phase 2: Treatment initiation (1-2 months)
3
Phase 3: Response monitoring (6-10 months)
4
Phase 4: Long-term management (ongoing)

Ideal Candidates

Patients with stage 4 RCC, pancreatic or bone metastases, or those on targeted therapy/immunotherapy requiring treatment monitoring.

Secure Enrollment

Purchase Protocol

Complete the form below to begin your treatment journey with our comprehensive cancer care protocol

Personal Information
Billing Information
Shipping Information
Protocol Details
Renal Cell Carcinoma Stage 4
Stage 4 (Pancreas/Bone Mets)
$6,200
per enrollment
Special Instructions
Order Summary
Protocol Fee $6,200
Quantity 1
Processing Fee $150
Total Amount $6,350

* Required fields. All information is secure and confidential.